WO2013057066A3 - Composition de traitement - Google Patents

Composition de traitement Download PDF

Info

Publication number
WO2013057066A3
WO2013057066A3 PCT/EP2012/070376 EP2012070376W WO2013057066A3 WO 2013057066 A3 WO2013057066 A3 WO 2013057066A3 EP 2012070376 W EP2012070376 W EP 2012070376W WO 2013057066 A3 WO2013057066 A3 WO 2013057066A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment composition
volume
air
inert gas
metal compound
Prior art date
Application number
PCT/EP2012/070376
Other languages
English (en)
Other versions
WO2013057066A2 (fr
Inventor
Joanna Susan DAWSON
Jordan Todorov Petkov
Original Assignee
Unilever Plc
Unilever N.V.
Conopco, Inc., D/B/A Unilever
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Plc, Unilever N.V., Conopco, Inc., D/B/A Unilever filed Critical Unilever Plc
Publication of WO2013057066A2 publication Critical patent/WO2013057066A2/fr
Publication of WO2013057066A3 publication Critical patent/WO2013057066A3/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241Containing particulates characterized by their shape and/or structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0295Liquid crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • A61K8/416Quaternary ammonium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/12Preparations containing hair conditioners

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)

Abstract

L'invention porte sur une composition aérée comprenant au moins 5 % en volume d'air et/ou de gaz inerte à 20°C, un composé métallique particulaire et une phase lamellaire comprenant un tensioactif cationique et une matière grasse.
PCT/EP2012/070376 2011-10-17 2012-10-15 Composition de traitement WO2013057066A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11185365.1 2011-10-17
EP11185365 2011-10-17

Publications (2)

Publication Number Publication Date
WO2013057066A2 WO2013057066A2 (fr) 2013-04-25
WO2013057066A3 true WO2013057066A3 (fr) 2013-11-14

Family

ID=47010623

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/070376 WO2013057066A2 (fr) 2011-10-17 2012-10-15 Composition de traitement

Country Status (2)

Country Link
AR (1) AR088349A1 (fr)
WO (1) WO2013057066A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6875502B2 (ja) * 2016-09-19 2021-05-26 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 発泡性組成物、エアゾール製品、及び皮膚への感覚的な利益を改善するためのそれらの使用方法
US10463584B2 (en) 2016-09-23 2019-11-05 The Procter & Gamble Company Stable foam compositions and methods of using the same to provide enhanced sensory and visual benefits to skin

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022771A1 (fr) * 2000-09-13 2002-03-21 The Procter & Gamble Company Procede de fabrication de produits en mousse
US6586483B2 (en) * 2001-01-08 2003-07-01 3M Innovative Properties Company Foam including surface-modified nanoparticles
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US20110193032A1 (en) * 2010-02-05 2011-08-11 Tecona Technologies, Inc. Composition for making transparent conductive coating based on nanoparticle dispersion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10058384B4 (de) 2000-11-24 2004-12-16 Wella Aktiengesellschaft Kosmetisches oder dermatologisches Mittel in Form eines cremigen Permanentschaums oder einer stabil aufgeschäumten Creme, deren Verwendung und Verfahren zur Herstellung des Mittels
JP4165713B2 (ja) 2002-05-10 2008-10-15 ユニリーバー・ナームローゼ・ベンノートシヤープ コンディショニングシャンプー組成物
US7888308B2 (en) 2006-12-19 2011-02-15 Cp Kelco U.S., Inc. Cationic surfactant systems comprising microfibrous cellulose

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002022771A1 (fr) * 2000-09-13 2002-03-21 The Procter & Gamble Company Procede de fabrication de produits en mousse
US6586483B2 (en) * 2001-01-08 2003-07-01 3M Innovative Properties Company Foam including surface-modified nanoparticles
US20050186147A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
US20110193032A1 (en) * 2010-02-05 2011-08-11 Tecona Technologies, Inc. Composition for making transparent conductive coating based on nanoparticle dispersion

Also Published As

Publication number Publication date
WO2013057066A2 (fr) 2013-04-25
AR088349A1 (es) 2014-05-28

Similar Documents

Publication Publication Date Title
HUS2100024I1 (hu) Izoxazolint tartalmazó parazita-ellenes készítmények, ezek elõállítása és alkalmazása
IL252154A0 (en) Antibodies against dr5, preparations containing them and their uses
TWI365872B (en) Pyrazolecarboxanilides, processes for their preparation and compositions comprising them for controlling harmful fungi
WO2013017885A3 (fr) Compositions de brasage
WO2012061607A3 (fr) Compositions comprenant des nanostructures fonctionnalisées à base de carbone et procédés associés
IL227035B (en) Aminoindan amide compounds, preparations containing them and their uses
WO2014011911A3 (fr) Inhibiteurs d'irak et leurs utilisations
IL227815B (en) Pyrrolopyrazine-spirocyclic piperidine amide compounds, and preparations containing them and their uses
WO2012061290A3 (fr) Compositions pesticides et procédés associés
WO2012087288A3 (fr) Compositions de sels métalliques
WO2012116246A3 (fr) Compositions pesticides et procédés associés
WO2012101011A3 (fr) Nouveaux dérivés d'arylbenzocycloalkylamides
WO2012175970A3 (fr) Composition
WO2013055687A3 (fr) R(+)-n-formyl-propargyl-aminoindane
AP2012006232A0 (en) New association between 4-ä3-ÄCIS-hexahydrocyclopentaÄcÜpyrrol-2(1H)-YLÜpropoxyübenzamide and an Acetylcholinesterase inhibitor, and pharmaceutical compositions containing it.
WO2012118308A3 (fr) Composition contenant un dérivé de pyrazole destinée à prévenir et à traiter les maladies cardiovasculaires
IL225440A0 (en) Compounds of cyclohexane derivatives, preparations containing them and their uses
EP2641604A4 (fr) Composition contenant un styraxlignolide a ou son aglycone à titre de principe actif pour prévenir ou traiter l'asthme
WO2013057066A3 (fr) Composition de traitement
ZA201404386B (en) Metallurgical composition for the manufacture of ferrochrome
IL230655A0 (en) Derivatives n-hetero-converted in the amide ring, preparations containing them and their uses
WO2012139074A3 (fr) Migrastatines et leurs utilisations
WO2013062332A3 (fr) Composition anti-vieillissement vasculaire comprenant du syringarésinol
WO2012046876A3 (fr) Composition de lutte contre les maladies des plantes, et méthode de lutte contre les maladies des plantes
WO2011123819A3 (fr) Anticorps anti-epha3 pour le traitement du myélome multiple

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12770510

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12770510

Country of ref document: EP

Kind code of ref document: A2